Kai Liao

ORCID: 0009-0004-1376-9131
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA modifications and cancer
  • Mobile Health and mHealth Applications
  • Circular RNAs in diseases
  • Health Literacy and Information Accessibility
  • MicroRNA in disease regulation
  • Patient-Provider Communication in Healthcare
  • DNA Repair Mechanisms
  • Cancer-related Molecular Pathways

Yangzhou University
2018-2023

To develop a Chinese version of the Newest Vital Sign (NVS-CHN) instrument and evaluate its psychometric properties.To deal with cross-cultural adaptation problems, after translation NVS into Chinese, Delphi method was used for experts cognitive testing participants. A cross-sectional study including 351 participants conducted to assess validity NVS-CHN. Internal reliability, criterion validity, known-groups were investigated. The NVS-CHN further validated against suitable standard, Citizen...

10.1371/journal.pone.0190721 article EN cc-by PLoS ONE 2018-01-05

We previously described a nucleolar protein RSL1D1 but distributed throughout the nucleus in HCT116 colorectal cancer (CRC) cells to facilitate G1/S transition by inhibiting p53 signaling. Here, we found another protein, programmed cell death 11 (PDCD11), also with an "Extra-nucleolar" localization CRC regulate G2/M checkpoint. This directly interacts and HDM2 nucleoplasm, thereby recruiting for ubiquitination degradation. The ensuing downregulation of increases CDK1 level help pass Upon DNA...

10.1038/s41389-023-00501-2 article EN cc-by Oncogenesis 2023-12-07
Coming Soon ...